Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vertexyn Bioworks is a synthetic biology company based in Hangzhou, China, specializing in the biomanufacturing of high-value natural products and pharmaceutical intermediates. The company utilizes a proprietary platform to engineer microbial strains for the efficient production of vitamins, organic acids, and complex molecules used in the healthcare and nutrition industries. By replacing traditional chemical synthesis with sustainable fermentation processes, Vertexyn aims to reduce costs and environmental impact. Their portfolio includes a range of bio-based ingredients that serve as critical components for global pharmaceutical and nutraceutical supply chains. The company is backed by prominent venture capital firms and focuses on scaling up production for global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vertexyn Bioworks.